Last reviewed · How we verify

NCT03839953

Exercise Rehabilitation for Patients With Critical Limb Ischemia After Revascularization

Status unknown NA Last updated 28 May 2019
What this trial tests

NA trial testing Supervised Exercise Program in Peripheral Arterial Disease in 64 participants. Status unknown.

Timeline
15 February 2019
Primary endpoint
1 January 2020
1 July 2020

Quick facts

Lead sponsorUniversity of Calgary
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment64
Start date15 February 2019
Primary completion1 January 2020
Estimated completion1 July 2020
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Calgary

Who can join

18 and older, any sex, with Peripheral Arterial Disease or Critical Limb Ischemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Peripheral arterial disease (PAD) affects more than 200 million people worldwide. This disease occurs with narrowing and occlusion of arteries supplying oxygenated blood to the organs and limbs. Symptomatic patients typically experience leg pain with physical activity. More advanced disease states are referred to as critical limb ischemia (CLI), where patients may have leg pain at rest or non-healing wounds. Primary treatment of PAD involves risk factor management; smoking cessation, management of blood pressure, blood cholesterol, diabetes, and exercise prescription. Patients with CLI typically require interventions to reestablish blood supply to their limbs. There is currently minimal understanding of the role for exercise rehabilitation after revascularization procedures in this vulnerable population. This is the first clinical to understand the role of exercise for these patients. We hypothesize that exercise rehabilitation after revascularization will improve quality of life and functional capacity in these patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A systematic review of patient-reported outcome measures patients with chronic limb-threatening ischemia.
    Goodney P, Shah S, Hu YD, Suckow B, et al · · 2022 · cited 23× · PMID 35085747 · DOI 10.1016/j.jvs.2021.11.057

Verify or expand the search:

Other trials of Supervised Exercise Program

Trials testing the same drug.

Other recruiting trials for Peripheral Arterial Disease

Currently open trials in the same condition.

Other University of Calgary trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03839953.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing